Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Janice P. Tzeng"'
Autor:
Sarah E Ray, Vanessa Boudewyns, Christine Davis, Janice P Tzeng, Ila Srivastava, Oluwamurewa Oguntimein, Denise S Conti, Karen B Feibus
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 17:1751-1768
Sarah E Ray,1 Vanessa Boudewyns,1 Christine Davis,1 Janice P Tzeng,1 Ila Srivastava,2 Oluwamurewa Oguntimein,3 Denise S Conti,4 Karen B Feibus2 1Center for Communication Science, RTI International, Research Triangle Park, NC, USA; 2Office of Research
Autor:
Holly Landrum Peay, Ryan Fischer, Janice P Tzeng, Sharon E Hesterlee, Carl Morris, Amy Strong Martin, Colin Rensch, Edward Smith, Valeria Ricotti, Katherine Beaverson, Hannah Wand, Carol Mansfield
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0213649 (2019)
ObjectivesDuchenne muscular dystrophy (DMD) is a rare neuromuscular disorder that causes progressive weakness and early death. Gene therapy is an area of new therapeutic development. This qualitative study explored factors influencing parents' and ad
Externí odkaz:
https://doaj.org/article/dc50ddcfc3d940448acd1b9d4749a014
Autor:
Helen Sullivan, Amie C. O’Donoghue, Janice P. Tzeng, Vanessa Boudewyns, Kate Ferriola-Bruckenstein
Publikováno v:
Oncologist
Background Understanding treatment options is important for patients with cancer and their caregivers. This may be difficult, however, because oncology treatments are often approved based on complex clinical endpoints. The study aimed to explore lay
Publikováno v:
PLoS ONE, Vol 3, Iss 5, p e2128 (2008)
Disclosure of authors' financial interests has been proposed as a strategy for protecting the integrity of the biomedical literature. We examined whether authors' financial interests were disclosed consistently in articles on coronary stents publishe
Externí odkaz:
https://doaj.org/article/5be663254a7b467c96eabe978c15bd79
Autor:
Lauren McCormack, Amie C. O’Donoghue, Janice P. Tzeng, Tania Fitzgerald, Suzanne L. West, Oluwamurewa Oguntimein, Julia Kish-Doto, Monica Scales, Paula Eguino-Medina
Publikováno v:
Journal of Health Communication. 19:77-88
This study investigated respondent preferences on how best to display patient medication information (PMI) that accompanies prescription medications to promote comprehension and appropriate usage. The authors identified 30 individuals diagnosed with
Autor:
Valeria Ricotti, Carol Mansfield, Sharon E. Hesterlee, Janice P. Tzeng, Amy Strong Martin, Hannah Wand, Holly L. Peay, Ryan Fischer, Carl Morris, Katherine Beaverson, Edward C. Smith, Colin Rensch
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 5, p e0213649 (2019)
PLoS ONE, Vol 14, Iss 5, p e0213649 (2019)
ObjectivesDuchenne muscular dystrophy (DMD) is a rare neuromuscular disorder that causes progressive weakness and early death. Gene therapy is an area of new therapeutic development. This qualitative study explored factors influencing parents' and ad
Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool
Autor:
Jeanette Renaud, Nedra Whitehead, Claudia Squire, Linda Squiers, Janice P. Tzeng, Roger Osborn, Douglas Rupert, Robert Furberg
Publikováno v:
Patient Education and Counseling. 92:188-196
A B S T R A C T Objective: Women with hereditary breast and ovarian cancer syndrome (HBOC) face a higher risk of earlier, more aggressive cancer. Because of HBOC’s rarity, screening is recommended only for women with strong cancer family histories.
Publikováno v:
Psycho-Oncology. 20:28-35
Background: Genomic recurrence risk test results now inform clinical decisions about adjuvant treatment for women with early-stage breast cancer. We sought to understand patients' knowledge of these tests and correlates of their knowledge. Methods: P
Autor:
Alice R. Richman, Janice P. Tzeng, Lisa A. Carey, Isaac M. Lipkus, Deborah K. Mayer, Carmina G. Valle, Paul K. J. Han, Noel T. Brewer
Publikováno v:
Cancer. 116:1992-2000
BACKGROUND: Few studies have examined how patients understand and use genomic test results when deciding about treatment. This study examined how women receive and incorporate results of Oncotype DX, a genomic test that offers recurrence risk estimat
Autor:
Elizabeth A. Hahn, Diana D. Jeffery, Bryce B. Reeve, Kevin P. Weinfurt, Janice P. Tzeng, Kathryn E. Flynn, Laura S. Porter, Francis J. Keefe
Publikováno v:
Cancer. 115:1142-1153
For this report, the authors described the initial activities of the Cancer Patient-Reported Outcomes Measurement Information System (PROMIS)-Sexual Function domain group, which is part of the National Institutes of Health Roadmap Initiative to devel